VisCardia Secures $40 Million Growth Financing to Advance VisONE™ Heart Failure Therapy Toward PMA Approval
/
DateDec 02 2025
PORTLAND, OR, UNITED STATES, December 2, 2025 /EINPresswire.com/ — VisCardia, Inc., a medical device company pioneering a novel cardiac-support therapy for patients with heart failure,... Read More →



















